Brigatinib in pretreated patients with ALK-positive advanced NSCLC.

被引：0

作者：

Descourt, Renaud

Perol, Maurice

Rousseau-Bussac, Gaelle

Planchard, David

Mennecier, Bertrand

Wislez, Marie

Cortot, Alexis B.

Guisier, Florian

Gervais, Radj

Galland, Loick

Schott, Roland

Dansin, Eric

Arrondeau, Jennifer

Auliac, Jean-Bernard

Chouaid, Christos

机构：

[1] CHU Morvan, Brest, France

[2] Ctr Leon Berard, Dept Thorac Oncol, Lyon, France

[3] CHI Creteil, Creteil, France

[4] Gustave Roussy, Dept Med Oncol, Thorac Grp, Villejuif, France

[5] Nouvel Hop Civil, Serv Pneumol, Strasbourg, France

[6] Hop Cochin & Tenon, Paris, France

[7] CHRU Lille, Lille, France

[8] CHU Rouen, Rouen, France

[9] CLCC Baclesse, Caen, France

[10] Ctr Georges Francois Leclerc, Dijon, France

[11] Paul Strauss Canc Ctr, Strasbourg, France

[12] Ctr Oscar Lambret, Lille, France

[13] Hop Cochin, Paris, France

[14] CHI Creteil, Creteil, France

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9045

引用

页数：1